Azenta (AZTA) Total Non-Current Liabilities (2010 - 2026)
Azenta (AZTA) posted quarterly Total Non-Current Liabilities of $338.3 million for Q1 2026, up 2.99% year-over-year from $328.5 million in Q1 2025, and down 2.82% quarter-over-quarter from $348.1 million in Q4 2025.
Azenta (AZTA) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Total Non-Current Liabilities for 17 consecutive years, with $338.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 2.99% year-over-year to $338.3 million; the TTM figure through Mar 2026 stood at $338.3 million (up 2.99% YoY), while the FY2025 annual figure was $348.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities fell to $338.3 million in Q1 2026 per AZTA's latest filing, from $348.1 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $686.9 million in Q1 2022 and bottomed at $294.9 million in Q2 2022.
- Historically, Total Non-Current Liabilities has averaged $358.5 million across 5 years, with a median of $338.3 million in 2026.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 81.55% — and 2023, when it slumped 48.58%.
- Azenta's Total Non-Current Liabilities stood at $402.5 million in 2022, then decreased by 8.49% to $368.3 million in 2023, then decreased by 14.65% to $314.4 million in 2024, then grew by 10.74% to $348.1 million in 2025, then decreased by 2.82% to $338.3 million in 2026.
- Business Quant data shows AZTA's Total Non-Current Liabilities at $338.3 million in Q1 2026, $348.1 million in Q4 2025, and $321.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.69 Bn | 129.47 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.58 Bn | 51.71 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.75 Bn | 34.39 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.89 Bn | 32.42 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.13 Bn | 26.45 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Azenta | 1.68 Bn | 1.36 Bn | 198.10 Mn | 355.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 355.36 Mn |
| Mar 31, 2026 | 338.32 Mn |
| Dec 31, 2025 | 348.13 Mn |
| Sep 30, 2025 | 321.45 Mn |
| Jun 30, 2025 | 345.55 Mn |
| Mar 31, 2025 | 328.50 Mn |
| Dec 31, 2024 | 314.37 Mn |
| Sep 30, 2024 | 323.15 Mn |
| Jun 30, 2024 | 321.31 Mn |
| Mar 31, 2024 | 329.02 Mn |
| Dec 31, 2023 | 368.33 Mn |
| Sep 30, 2023 | 339.05 Mn |
| Jun 30, 2023 | 333.15 Mn |
| Mar 31, 2023 | 353.19 Mn |
| Dec 31, 2022 | 402.53 Mn |
| Sep 30, 2022 | 346.01 Mn |
| Jun 30, 2022 | 294.93 Mn |
| Mar 31, 2022 | 686.91 Mn |
| Dec 31, 2021 | 483.14 Mn |
| Sep 30, 2021 | 488.01 Mn |